Table 3.

Secondary outcomes at 6 and 12 months follow-up

	Unadjusted model					Adjusted model
	β	CI lower	CI upper	t	p value	β	CI lower	CI upper	t	p value
Medication Adherence Rating Scale (MARS) 6 months, N = 82	0.51	−0.52	1.55	0.97	0.35	0.32	−0.82	1.45	0.55	0.60
Medication Adherence Rating Scale (MARS) 12 months, N = 14	−0.71	−3.03	1.61	−0.60	0.58	0.26	−1.97	2.49	0.23	0.83
Well-being (WHO5) 6 months, N = 83	3.80	−8.97	16.57	0.58	0.57	3.96	−10.32	18.23	0.54	0.60
Quality of Life (EurohisQuol) 6 months, N = 83	1.99	−0.99	4.97	1.31	0.22	1.59	−1.47	4.64	1.02	0.33
	OR	CI lower	CI upper	z	p value	OR	CI lower	CI upper	z	p value
Rehospitalisation within 12 months 42/113 (37%) (intervention) 36/116 (31%)(control), N = 229	1.31	0.76	2.27	0.98	0.33	1.39	0.78	2.47	1.13	0.26